NOF Corporation

NOF Corporation manufactures chemicals in Japan. The company operates through Functional Chemicals, Life Science, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, and electronic materials, as well as special corrosion prevention agents. The Life Science segment provides edible oils, functional foods, activated PEG, functional lipids, surfactants for drugs, biocompatible materials, plant-derived ingredients, and MPC polymer/monomer. The Explosive & Propulsion segment offers industrial explosives, solid propellants, pyrotechnic devices, gun propellant/rocket propellant, guided missile assemblies, anti-freezing agents, and temperature and sterilization indicators. It is also involved in logistics, insurance agency, and real estate businesses. The company was founded in 1937 and is headquartered in Tokyo, Japan.

NOF Corporation trades as NOFCF on OTC. The company is classified in Basic Materials / Chemicals - Specialty and reports in USD.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $259.59B of revenue and $40.81B of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

NOF Corporation can be compared against peers such as Air Products and Chemicals, Inc., Axalta Coating Systems Ltd., The Chemours Company, Ecolab Inc., Element Solutions Inc, H.B. Fuller Company.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $4.04B, beta of 0.35, and return on equity of +13.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NOFCF currently shows total debt of $5.17B and beta of 0.35. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nof.co.jp

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.